dimyristoylphosphatidylglycerol has been researched along with 5,11-dimethyl-5h-indolo(2,3-b)quinoline in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Godlewska, J; Gubernator, J; Kaczmarek, Ł; Kociubińska, A; Kozubek, A; Opolski, A; Peczyńska-Czoch, W; Stasiuk, M | 1 |
1 other study(ies) available for dimyristoylphosphatidylglycerol and 5,11-dimethyl-5h-indolo(2,3-b)quinoline
Article | Year |
---|---|
A derivative of 5-H-indolo[2,3-b]quinoline--a novel liposomally-formulated anticancer agent.
Topics: Antineoplastic Agents; Carbolines; Dimyristoylphosphatidylcholine; Drug Carriers; Humans; Liposomes; Phosphatidylglycerols; Topoisomerase II Inhibitors; Tumor Cells, Cultured | 2002 |